Provided by Tiger Fintech (Singapore) Pte. Ltd.

Immunome Inc.

16.07
+0.09000.56%
Post-market: 16.070.00000.00%19:58 EDT
Volume:732.92K
Turnover:11.79M
Market Cap:1.40B
PE:-5.47
High:16.44
Open:15.93
Low:15.64
Close:15.98
52wk High:17.32
52wk Low:5.15
Shares:87.05M
Float Shares:70.81M
Volume Ratio:0.75
T/O Rate:1.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.9374
EPS(LYR):-4.9960
ROE:-81.20%
ROA:-40.20%
PB:5.19
PE(LYR):-3.22

Loading ...

Immunome Inc. to Present at Guggenheim Healthcare Innovation Conference

Reuters
·
Oct 31

argenx Reports Third Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire
·
Oct 30

Cabaletta Bio Presents Positive Clinical Data and Development Updates for Rese-cel at ACR Convergence 2025

GlobeNewswire
·
Oct 27

Craig-Hallum Reaffirms Their Buy Rating on Immunome (IMNM)

TIPRANKS
·
Oct 24

Immunome presents preclinical data on ADC payload HC74

TIPRANKS
·
Oct 24

Immunome Unveils Preclinical Data Showing HC74 ADC Payload Overcomes Drug Resistance in Cancer Models

Reuters
·
Oct 24

Immunome Inc. Grants Stock Options to New Employees Under 2024 Inducement Plan

Reuters
·
Oct 03

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Oct 03

Immunome (IMNM) Gets a Buy from Evercore ISI

TIPRANKS
·
Sep 24

Leerink Partners Keeps Their Buy Rating on Immunome (IMNM)

TIPRANKS
·
Sep 24

Immunome’s Promising Oncology Pipeline and Strong Market Potential Justify Buy Rating

TIPRANKS
·
Sep 24

Immunome Initiated at Buy by Goldman Sachs

Dow Jones
·
Sep 22

Goldman Sachs Initiates Immunome at Buy With $26 Price Target

MT Newswires Live
·
Sep 22

Immunome announces novel antibody collaboration with Infinimmune

TIPRANKS
·
Sep 18

Infinimmune Announces Research Collaboration With Immunome

THOMSON REUTERS
·
Sep 18

Infinimmune: Financial Terms of Deal Were Not Disclosed

THOMSON REUTERS
·
Sep 18

Evercore ISI Reaffirms Their Buy Rating on Immunome (IMNM)

TIPRANKS
·
Sep 18

Immunome (IMNM) Gets a Buy from Guggenheim

TIPRANKS
·
Sep 15

Immunome Initiated at Buy by Craig-Hallum

Dow Jones
·
Sep 05

Craig-Hallum Initiates Immunome at Buy With $26 Price Target

MT Newswires Live
·
Sep 05